LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2011 fiscal year, ended February 28, 2011, with the U.S. Securities and Exchange Commission on Wednesday, April 13, 2011. Chairman and CEO Walt Woltosz will host a conference call to discuss the Company’s performance on Monday, April 18, at 1:15 p.m. PDT / 4:15 p.m. EDT.
The conference call will also be webcast live and may be accessed by first registering at the following website: https://www2.gotomeeting.com/register/366534586/. Upon registering, you will receive a confirmation e-mail with a unique link and instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial 773-945-1010 and enter access code 445-447-672.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. The Company’s Words+, Inc., wholly owned subsidiary provides augmentative communication systems and other technologies for persons with disabilities. Simulations Plus is headquartered in Southern California. For more information, visit our web site at www.simulations-plus.com.